Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 136.72% | 9.50% | -46.27% | -59.23% | -43.36% |
| Total Depreciation and Amortization | 79.81% | 149.55% | 529.12% | 373.15% | 227.38% |
| Total Amortization of Deferred Charges | 160.66% | 595.45% | -- | -- | -- |
| Total Other Non-Cash Items | -103.02% | -2,916.13% | -53.85% | -15.56% | -115.42% |
| Change in Net Operating Assets | -41.62% | 304.77% | 323.00% | 274.27% | 373.29% |
| Cash from Operations | 52.08% | 128.50% | 23.93% | 54.94% | 22.17% |
| Capital Expenditure | 99.97% | 99.99% | -49,607.45% | -53,260.00% | -55,486.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.91% | 100.05% | -49,607.45% | -53,260.00% | -55,486.11% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -15,052.79% | -13,613.07% | -12,465.57% | -146.49% | -109.91% |
| Issuance of Common Stock | 41.45% | -69.67% | -85.56% | -82.83% | -64.32% |
| Repurchase of Common Stock | -2,957.39% | 29.45% | 60.38% | 100.00% | 96.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 87.69% | -- | -- | -- |
| Cash from Financing | -202.99% | -189.85% | 536.46% | 840.95% | 849.35% |
| Foreign Exchange rate Adjustments | 160.18% | -176.83% | 166.87% | -353.04% | -307.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 52.96% | 96.62% | -414.66% | -333.59% | -300.09% |